<code id='816FED04B1'></code><style id='816FED04B1'></style>
    • <acronym id='816FED04B1'></acronym>
      <center id='816FED04B1'><center id='816FED04B1'><tfoot id='816FED04B1'></tfoot></center><abbr id='816FED04B1'><dir id='816FED04B1'><tfoot id='816FED04B1'></tfoot><noframes id='816FED04B1'>

    • <optgroup id='816FED04B1'><strike id='816FED04B1'><sup id='816FED04B1'></sup></strike><code id='816FED04B1'></code></optgroup>
        1. <b id='816FED04B1'><label id='816FED04B1'><select id='816FED04B1'><dt id='816FED04B1'><span id='816FED04B1'></span></dt></select></label></b><u id='816FED04B1'></u>
          <i id='816FED04B1'><strike id='816FED04B1'><tt id='816FED04B1'><pre id='816FED04B1'></pre></tt></strike></i>

          fashion

          fashion

          author:knowledge    Page View:5
          Mississippi Delta Region, pulse oximeter
          Pulse oximeters, which track blood oxygen levels, can overestimate such levels in patients with darker skin, potentially providing reassurance instead of indicating they need to be treated. Spencer Platt/Getty Images

          LONDON — Regulators, clinicians, and health care algorithm developers need to take additional steps to ensure that medical devices work equally well for all patients, avoiding blind spots that can lead to worse care for patients from underrepresented racial and ethnic groups, according to a U.K.-commissioned review released on Monday.

          The report, which also warned about the products’ biases potentially hurting women and people from lower socioeconomic groups, called on the government to improve its understanding of the devices used commonly in the country’s health service, with a need for an expert panel that can assess the possible unintended consequences as AI tools expand. Providers also need to learn about the limitations of these devices, to ensure they don’t result in poor patient care.

          advertisement

          The report cited several examples, including evidence that pulse oximeters, which track blood oxygen levels, can overestimate such levels in patients with darker skin, potentially providing reassurance instead of indicating they need to be treated.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more
          Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

          AllenG.Breed/APNewbiotechnewsletterlaunchingthisThursday.Don’tmissout.Heythere.Today,wediscusstheimp

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

          ThisistheinauguraleditionofAdam’sBiotechScorecard,anewsubscriber-onlynewsletter.STAT+subscriberscans